Paul C Lambert

发表

Temporal recalibration for improving prognostic model development and risk predictions in settings where survival is improving over time

Richard D Riley, Joie Ensor, Sarah Booth, 2020, International journal of epidemiology.

Comments on ‘Trying to be precise about vagueness’ by Stephen Senn, Statistics in Medicine 2007; 26:1417–1430

Alex J Sutton, Keith R Abrams, David R Jones, 2008, Statistics in medicine.

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.

Alexander J Sutton, Paul C Lambert, Michael J Sweeting, 2004, Statistics in medicine.

The Estimation and Modeling of Cause-specific Cumulative Incidence Functions Using Time-dependent Weights

Paul C Lambert, P. Lambert, 2017, The Stata journal.

Evidence‐based sample size calculations based upon updated meta‐analysis

Nicola J Cooper, Keith R Abrams, David R Jones, 2007, Statistics in medicine.

Meta‐analysis of continuous outcomes combining individual patient data and aggregate data

Richard D Riley, Jan A Staessen, Jiguang Wang, 2008, Statistics in medicine.

Flexible parametric modelling of the cause‐specific cumulative incidence function

Michael J Crowther, Paul C Lambert, Sally R Wilkes, 2017, Statistics in medicine.

A Flexible Parametric Competing-risks Model Using a Direct Likelihood Approach for the Cause-specific Cumulative Incidence Function

Paul C Lambert, Mark J Rutherford, Sarwar Islam Mozumder, 2017, The Stata journal.

Simulating biologically plausible complex survival data

Michael J Crowther, Paul C Lambert, P. Lambert, 2013, Statistics in medicine.

Parametric multistate survival models: Flexible modelling allowing transition‐specific distributions with application to estimating clinically useful measures of effect differences

Michael J Crowther, Paul C Lambert, P. Lambert, 2017, Statistics in medicine.

Cost-Effectiveness Analysis Using Data from Multinational Trials: The Use of Bivariate Hierarchical Modeling

Nigel Rice, Andrea Manca, Mark Sculpher, 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

Predicting costs over time using Bayesian Markov chain Monte Carlo methods: an application to early inflammatory polyarthritis.

Nicola J Cooper, Keith R Abrams, Alexander J Sutton, 2007, Health economics.

Flexible parametric joint modelling of longitudinal and survival data

Keith R Abrams, Michael J Crowther, Paul C Lambert, 2012, Statistics in medicine.

Estimating causal effects in the presence of competing events using regression standardisation with the Stata command standsurv

Paul C Lambert, Mark J Rutherford, Elisavet Syriopoulou, 2021, BMC Medical Research Methodology.

Screening and cervical cancer cure: population based cohort study

Joakim Dillner, Pär Sparén, Paul C Lambert, 2012, BMJ : British Medical Journal.

The impact of under and over-recording of cancer on death certificates in a competing risks analysis: a simulation study.

Keith R Abrams, Paul C Lambert, Sally R. Hinchliffe, 2013, Cancer epidemiology.

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Anne M Johnson, Kholoud Porter, Paul C Lambert, 2008, JAMA.

Flexible parametric models for relative survival, with application in coronary heart disease

Paul C Lambert, Iain B Squire, David R. Jones, 2007, Statistics in medicine.

Beyond the Bench: Hunting Down Fugitive Literature

Richard D Riley, Keith R Abrams, Alexander J Sutton, 2004, Environmental Health Perspectives.

Meta‐analysis of heterogeneously reported trials assessing change from baseline

Keith R Abrams, Paul C Lambert, K. Abrams, 2005, Statistics in medicine.

A general framework for parametric survival analysis

Michael J Crowther, Paul C Lambert, P. Lambert, 2014, Statistics in medicine.

Estimating and modeling the cure fraction in population-based cancer survival analysis.

Paul W Dickman, Paul C Lambert, Claire L Weston, 2007, Biostatistics.

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

Nicola J Cooper, Alex J Sutton, Keith R Abrams, 2008, BMJ : British Medical Journal.

The analysis of peak expiratory flow data using a three-level hierarchical model.

Keith R Abrams, Paul C Lambert, Paul R Burton, 2004, Statistics in medicine.

Estimating the loss in expectation of life due to cancer using flexible parametric survival models

Mats Lambe, Paul W Dickman, Paul C Lambert, 2013, Statistics in medicine.

Additive and multiplicative covariate regression models for relative survival incorporating fractional polynomials for time‐dependent effects

Paul C Lambert, David R. Jones, P. Lambert, 2005, Statistics in medicine.

Adjusting Survival Time Estimates to Account for Treatment Switching in Randomized Controlled Trials—an Economic Evaluation Context

Keith R Abrams, Michael J Crowther, Nicholas R Latimer, 2014, Medical decision making : an international journal of the Society for Medical Decision Making.

Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions

Paul C Lambert, Sally R. Hinchliffe, P. Lambert, 2013, BMC Medical Research Methodology.

Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models

Paul W Dickman, Kamila Czene, Paul C Lambert, 2012, BMC Medical Research Methodology.

Adjusting for measurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach

Keith R Abrams, Michael J Crowther, Paul C Lambert, 2013, BMC Medical Research Methodology.

Providing more up-to-date estimates of patient survival: a comparison of standard survival analysis with period analysis using life-table methods and proportional hazards models.

Paul C Lambert, David R. Jones, P. Lambert, 2004, Journal of clinical epidemiology.

A Systematic Review of Molecular and Biological Tumor Markers in Neuroblastoma

Richard D Riley, Alex J Sutton, Keith R Abrams, 2004, Clinical Cancer Research.

Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present.

Richard D Riley, Alex J Sutton, Keith R Abrams, 2004, Journal of clinical epidemiology.

Individual patient data meta-analysis of survival data using Poisson regression models

Richard D Riley, Michael J Crowther, Jan A Staessen, 2012, BMC Medical Research Methodology.

Life Expectancy of Patients With Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population.

Paul W Dickman, Paul C Lambert, Hannah Bower, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Urinary microalbumin/creatinine ratios: reference range in uncomplicated pregnancy.

Paul C Lambert, Andrew Shennan, M. Kilby, 2003, Clinical science.

Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover.

Paul C Lambert, Paul R Burton, Rosy Reynolds, 2008, The Journal of antimicrobial chemotherapy.

Estimating the cost-effectiveness of an intervention in a clinical trial when partial cost information is available: a Bayesian approach.

Nicola J Cooper, Alex J Sutton, Keith R Abrams, 2008, Health economics.

Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study

Keith R Abrams, Michael J Crowther, Nicholas R Latimer, 2018, Statistical methods in medical research.

Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models

Paul W Dickman, Paul C Lambert, Sandra Eloranta, 2011, BMC medical research methodology.

A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty.

Nicola J Cooper, Keith R Abrams, Alexander J Sutton, 2005, Journal of clinical epidemiology.

Meta-analysis of rare and adverse event data

Nicola J Cooper, Keith R Abrams, Alexander J Sutton, 2002, Expert review of pharmacoeconomics & outcomes research.

Quantifying differences in breast cancer survival between England and Norway.

Henrik Møller, Paul C Lambert, David Robinson, 2011, Cancer epidemiology.

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

Nicola J Cooper, Alex J Sutton, Keith R Abrams, 2007, BMJ : British Medical Journal.